| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepacivirus | 25 | 2023 | 131 | 7.660 |
Why?
|
| Virus Replication | 31 | 2023 | 326 | 5.200 |
Why?
|
| Hepatitis C | 11 | 2023 | 174 | 3.730 |
Why?
|
| Virus Internalization | 14 | 2023 | 40 | 3.160 |
Why?
|
| Viral Nonstructural Proteins | 11 | 2021 | 40 | 3.130 |
Why?
|
| Dengue Virus | 10 | 2022 | 43 | 2.810 |
Why?
|
| Host-Pathogen Interactions | 13 | 2022 | 237 | 2.370 |
Why?
|
| Lipid Metabolism | 10 | 2018 | 201 | 2.190 |
Why?
|
| Virus Release | 4 | 2019 | 6 | 1.870 |
Why?
|
| RNA, Viral | 8 | 2018 | 318 | 1.800 |
Why?
|
| Autophagy | 7 | 2018 | 159 | 1.790 |
Why?
|
| Cell Membrane | 6 | 2019 | 677 | 1.670 |
Why?
|
| Antiviral Agents | 10 | 2022 | 482 | 1.640 |
Why?
|
| Membrane Lipids | 3 | 2016 | 41 | 1.340 |
Why?
|
| Viruses | 4 | 2019 | 78 | 1.300 |
Why?
|
| Hepatocytes | 6 | 2021 | 122 | 1.250 |
Why?
|
| Dengue | 5 | 2022 | 44 | 1.230 |
Why?
|
| Virus Assembly | 4 | 2019 | 21 | 1.170 |
Why?
|
| Claudin-1 | 2 | 2023 | 17 | 1.060 |
Why?
|
| Viral Proteins | 8 | 2022 | 302 | 1.030 |
Why?
|
| Endocytosis | 5 | 2019 | 180 | 1.000 |
Why?
|
| Cell Line | 16 | 2022 | 2495 | 0.980 |
Why?
|
| RNA Viruses | 2 | 2016 | 10 | 0.940 |
Why?
|
| Interferons | 3 | 2023 | 127 | 0.920 |
Why?
|
| Virus Diseases | 3 | 2013 | 99 | 0.880 |
Why?
|
| Cell Culture Techniques | 2 | 2021 | 194 | 0.820 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2014 | 80 | 0.800 |
Why?
|
| Organoids | 2 | 2021 | 65 | 0.750 |
Why?
|
| Interferon-gamma | 1 | 2023 | 449 | 0.740 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 755 | 0.720 |
Why?
|
| Gene Expression Regulation, Viral | 6 | 2022 | 93 | 0.700 |
Why?
|
| RNA Interference | 5 | 2011 | 376 | 0.700 |
Why?
|
| Flavivirus | 2 | 2018 | 6 | 0.700 |
Why?
|
| Fatty Acids | 2 | 2010 | 134 | 0.690 |
Why?
|
| Extracellular Vesicles | 2 | 2022 | 42 | 0.680 |
Why?
|
| Immunity, Innate | 5 | 2022 | 434 | 0.670 |
Why?
|
| Receptors, Virus | 4 | 2021 | 75 | 0.650 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 399 | 0.640 |
Why?
|
| Virion | 2 | 2017 | 59 | 0.620 |
Why?
|
| Optical Imaging | 1 | 2019 | 51 | 0.610 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 280 | 0.600 |
Why?
|
| Lipids | 1 | 2019 | 275 | 0.590 |
Why?
|
| Adenylate Kinase | 1 | 2017 | 13 | 0.580 |
Why?
|
| Proviruses | 1 | 2017 | 15 | 0.580 |
Why?
|
| Humans | 53 | 2024 | 89968 | 0.540 |
Why?
|
| Endoplasmic Reticulum | 4 | 2016 | 255 | 0.540 |
Why?
|
| Flavivirus Infections | 1 | 2016 | 5 | 0.540 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 96 | 0.540 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 189 | 0.510 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 557 | 0.500 |
Why?
|
| Animals | 30 | 2024 | 27528 | 0.490 |
Why?
|
| Phosphatidylinositols | 1 | 2014 | 20 | 0.490 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2014 | 1 | 0.470 |
Why?
|
| Cyclophilin A | 1 | 2014 | 4 | 0.460 |
Why?
|
| Cyclosporins | 1 | 2014 | 58 | 0.460 |
Why?
|
| Imidazoles | 1 | 2014 | 140 | 0.460 |
Why?
|
| Receptors, Steroid | 1 | 2014 | 42 | 0.450 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 603 | 0.450 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2013 | 21 | 0.430 |
Why?
|
| Herpesvirus 1, Human | 4 | 2000 | 245 | 0.420 |
Why?
|
| Cholesterol | 2 | 2014 | 360 | 0.420 |
Why?
|
| RNA | 2 | 2023 | 583 | 0.410 |
Why?
|
| DNA Viruses | 1 | 2012 | 16 | 0.410 |
Why?
|
| Vesicle-Associated Membrane Protein 1 | 1 | 2012 | 1 | 0.400 |
Why?
|
| MicroRNAs | 5 | 2022 | 556 | 0.400 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 43 | 0.380 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2011 | 15 | 0.380 |
Why?
|
| Occludin | 2 | 2023 | 66 | 0.370 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 130 | 0.370 |
Why?
|
| Golgi Apparatus | 1 | 2012 | 116 | 0.370 |
Why?
|
| Mice | 16 | 2024 | 11851 | 0.370 |
Why?
|
| Fatty Acid Synthases | 1 | 2010 | 8 | 0.360 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 284 | 0.360 |
Why?
|
| Virus Latency | 3 | 2000 | 33 | 0.360 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 281 | 0.350 |
Why?
|
| Genes, Viral | 1 | 2009 | 117 | 0.340 |
Why?
|
| Protein Interaction Mapping | 3 | 2022 | 81 | 0.330 |
Why?
|
| Protein Transport | 4 | 2019 | 423 | 0.300 |
Why?
|
| ErbB Receptors | 2 | 2023 | 499 | 0.300 |
Why?
|
| Minor Histocompatibility Antigens | 3 | 2014 | 39 | 0.300 |
Why?
|
| HEK293 Cells | 4 | 2022 | 646 | 0.300 |
Why?
|
| Pyrrolidines | 2 | 2021 | 60 | 0.300 |
Why?
|
| Kidney | 2 | 2022 | 1148 | 0.280 |
Why?
|
| Endoribonucleases | 3 | 2022 | 94 | 0.270 |
Why?
|
| Gene Silencing | 2 | 2006 | 178 | 0.260 |
Why?
|
| Endopeptidases | 1 | 2006 | 118 | 0.260 |
Why?
|
| Interferon-alpha | 1 | 2006 | 214 | 0.260 |
Why?
|
| Protein Binding | 5 | 2022 | 1491 | 0.250 |
Why?
|
| Genome, Viral | 3 | 2018 | 82 | 0.240 |
Why?
|
| gamma-Globulins | 1 | 2024 | 16 | 0.230 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 123 | 0.230 |
Why?
|
| Clathrin | 1 | 2023 | 29 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2022 | 1983 | 0.230 |
Why?
|
| Melphalan | 1 | 2024 | 98 | 0.220 |
Why?
|
| Antibodies, Viral | 3 | 2021 | 311 | 0.220 |
Why?
|
| Open Reading Frames | 3 | 2000 | 121 | 0.220 |
Why?
|
| Replicon | 1 | 2002 | 7 | 0.210 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 74 | 0.210 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 11 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2022 | 8 | 0.200 |
Why?
|
| Pluripotent Stem Cells | 1 | 2022 | 34 | 0.200 |
Why?
|
| A549 Cells | 4 | 2022 | 42 | 0.190 |
Why?
|
| Coronavirus OC43, Human | 1 | 2021 | 7 | 0.190 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2022 | 56 | 0.190 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 53 | 0.190 |
Why?
|
| Adaptor Protein Complex 1 | 2 | 2018 | 2 | 0.190 |
Why?
|
| Signal Transduction | 4 | 2017 | 3404 | 0.190 |
Why?
|
| Papain | 1 | 2021 | 6 | 0.190 |
Why?
|
| Thymine | 1 | 2021 | 17 | 0.190 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 66 | 0.190 |
Why?
|
| Immunoconjugates | 1 | 2021 | 114 | 0.180 |
Why?
|
| Thiazoles | 1 | 2021 | 127 | 0.180 |
Why?
|
| Peptide Hydrolases | 1 | 2021 | 101 | 0.180 |
Why?
|
| Caliciviridae Infections | 1 | 2020 | 10 | 0.180 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 2587 | 0.180 |
Why?
|
| Disease Resistance | 1 | 2020 | 18 | 0.180 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 399 | 0.180 |
Why?
|
| Nanoparticles | 1 | 2021 | 164 | 0.170 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 136 | 0.170 |
Why?
|
| Tetraspanin 28 | 2 | 2018 | 3 | 0.170 |
Why?
|
| Cells | 1 | 2019 | 32 | 0.170 |
Why?
|
| Base Sequence | 5 | 2007 | 2329 | 0.160 |
Why?
|
| Herpes Simplex | 1 | 2000 | 203 | 0.160 |
Why?
|
| Exoribonucleases | 1 | 2018 | 9 | 0.160 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2018 | 4 | 0.160 |
Why?
|
| Lipid Droplet Associated Proteins | 1 | 2018 | 1 | 0.160 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2018 | 13 | 0.160 |
Why?
|
| Lipid Droplets | 1 | 2018 | 16 | 0.150 |
Why?
|
| Liver | 2 | 2013 | 1211 | 0.150 |
Why?
|
| Staining and Labeling | 1 | 2019 | 169 | 0.150 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2018 | 4 | 0.150 |
Why?
|
| Adaptor Protein Complex 4 | 1 | 2018 | 2 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 644 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2018 | 1227 | 0.150 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 48 | 0.140 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 30 | 0.140 |
Why?
|
| Vero Cells | 4 | 2022 | 103 | 0.140 |
Why?
|
| Immediate-Early Proteins | 2 | 1997 | 164 | 0.140 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2017 | 88 | 0.140 |
Why?
|
| Tight Junctions | 1 | 2018 | 150 | 0.140 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 825 | 0.140 |
Why?
|
| DNA Replication | 1 | 2017 | 171 | 0.130 |
Why?
|
| Bromovirus | 1 | 2016 | 1 | 0.130 |
Why?
|
| Hordeum | 1 | 2016 | 10 | 0.130 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 49 | 0.130 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 139 | 0.130 |
Why?
|
| Flunarizine | 1 | 2015 | 1 | 0.130 |
Why?
|
| Pyrroles | 1 | 2017 | 172 | 0.130 |
Why?
|
| Viral Fusion Proteins | 1 | 2015 | 10 | 0.130 |
Why?
|
| Cell Survival | 1 | 2018 | 983 | 0.130 |
Why?
|
| Plant Diseases | 1 | 2016 | 76 | 0.130 |
Why?
|
| Glycolysis | 1 | 2016 | 135 | 0.130 |
Why?
|
| Indoles | 1 | 2017 | 300 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 289 | 0.120 |
Why?
|
| Carbamates | 1 | 2014 | 15 | 0.120 |
Why?
|
| Valine | 1 | 2014 | 62 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2018 | 678 | 0.120 |
Why?
|
| Actins | 1 | 2018 | 462 | 0.120 |
Why?
|
| Models, Molecular | 3 | 2021 | 1315 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 1997 | 1158 | 0.110 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2013 | 8 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 1576 | 0.110 |
Why?
|
| Viral Tropism | 1 | 2012 | 4 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 586 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 919 | 0.100 |
Why?
|
| RNA Virus Infections | 1 | 2012 | 3 | 0.100 |
Why?
|
| DNA Virus Infections | 1 | 2012 | 4 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1255 | 0.100 |
Why?
|
| Hepatitis Viruses | 1 | 2012 | 1 | 0.100 |
Why?
|
| Biological Assay | 1 | 2012 | 79 | 0.100 |
Why?
|
| Genotype | 4 | 2015 | 1853 | 0.100 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 102 | 0.100 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2012 | 22 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 64 | 0.100 |
Why?
|
| Virus Physiological Phenomena | 1 | 2011 | 8 | 0.100 |
Why?
|
| Calreticulin | 1 | 2011 | 13 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2022 | 86 | 0.100 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 44 | 0.100 |
Why?
|
| Phagosomes | 1 | 2011 | 39 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 1244 | 0.090 |
Why?
|
| Lung | 3 | 2022 | 1292 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2013 | 242 | 0.090 |
Why?
|
| Catalytic Domain | 2 | 2021 | 156 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2022 | 2026 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2011 | 285 | 0.090 |
Why?
|
| Cryoelectron Microscopy | 1 | 2011 | 102 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 167 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 388 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 1452 | 0.090 |
Why?
|
| Virus Attachment | 1 | 2009 | 6 | 0.090 |
Why?
|
| Cricetinae | 1 | 2010 | 558 | 0.090 |
Why?
|
| Gene Library | 1 | 2009 | 132 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 105 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 323 | 0.080 |
Why?
|
| Endosomes | 1 | 2009 | 79 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 3024 | 0.080 |
Why?
|
| Rabbits | 3 | 1997 | 640 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2021 | 895 | 0.070 |
Why?
|
| Macrophages | 2 | 2022 | 582 | 0.070 |
Why?
|
| Janus Kinase 1 | 1 | 2006 | 16 | 0.070 |
Why?
|
| Ubiquitins | 1 | 2006 | 38 | 0.070 |
Why?
|
| STAT1 Transcription Factor | 1 | 2006 | 53 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2007 | 201 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 66 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2007 | 227 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2331 | 0.060 |
Why?
|
| DNA | 2 | 2004 | 1311 | 0.060 |
Why?
|
| Herpesviridae | 1 | 2005 | 15 | 0.060 |
Why?
|
| DNA Probes | 1 | 2004 | 77 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2004 | 46 | 0.060 |
Why?
|
| Binding Sites | 3 | 2020 | 1121 | 0.060 |
Why?
|
| Viral Structural Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2005 | 354 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2024 | 31 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2004 | 179 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 2004 | 94 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 1 | 2005 | 241 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 1048 | 0.050 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2022 | 17 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 16 | 0.050 |
Why?
|
| Cytokines | 1 | 2006 | 811 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 693 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2022 | 93 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 466 | 0.050 |
Why?
|
| Virus Inactivation | 1 | 2021 | 4 | 0.050 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 23 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2022 | 80 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 15 | 0.050 |
Why?
|
| Semiconductors | 1 | 2021 | 11 | 0.050 |
Why?
|
| Thiadiazoles | 1 | 2021 | 12 | 0.050 |
Why?
|
| DNA Primers | 1 | 2002 | 543 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 1074 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 3252 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 64 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2022 | 689 | 0.050 |
Why?
|
| Polyproteins | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2887 | 0.050 |
Why?
|
| Uridine | 1 | 2021 | 56 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2021 | 207 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 151 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 178 | 0.050 |
Why?
|
| Viral Load | 1 | 2021 | 145 | 0.050 |
Why?
|
| Norovirus | 1 | 2020 | 13 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2020 | 28 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 515 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2021 | 169 | 0.040 |
Why?
|
| Polymers | 1 | 2021 | 196 | 0.040 |
Why?
|
| Light | 1 | 2021 | 292 | 0.040 |
Why?
|
| Gastroenteritis | 1 | 2020 | 26 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 234 | 0.040 |
Why?
|
| Piperidines | 1 | 2021 | 163 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2020 | 308 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2021 | 352 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 447 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1130 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 491 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 360 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 300 | 0.040 |
Why?
|
| Asthma | 1 | 2007 | 984 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 82 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1498 | 0.040 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 91 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 600 | 0.040 |
Why?
|
| Methionine | 1 | 1997 | 67 | 0.040 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Ebolavirus | 1 | 2017 | 7 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 56 | 0.040 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2017 | 12 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 283 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 246 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 307 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1997 | 212 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 2016 | 117 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 778 | 0.030 |
Why?
|
| Transfection | 1 | 1997 | 909 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1008 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 1765 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 387 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 1665 | 0.030 |
Why?
|
| Skin | 1 | 1997 | 589 | 0.030 |
Why?
|
| Phenotype | 2 | 1997 | 2458 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 2307 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2016 | 440 | 0.030 |
Why?
|
| Drug Resistance, Viral | 1 | 2012 | 48 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2011 | 30 | 0.020 |
Why?
|
| RNA Helicases | 1 | 2011 | 35 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2011 | 50 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 128 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 64 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 274 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2011 | 146 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2011 | 263 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 247 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 129 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 303 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 228 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 645 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 313 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 4168 | 0.020 |
Why?
|
| Female | 3 | 2022 | 46594 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 511 | 0.020 |
Why?
|
| HLA-G Antigens | 1 | 2007 | 52 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 95 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 727 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 477 | 0.020 |
Why?
|
| Motion | 1 | 2004 | 97 | 0.010 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 2004 | 2 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 19254 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 1139 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 346 | 0.010 |
Why?
|
| HIV-1 | 1 | 2004 | 167 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2004 | 468 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 431 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 1102 | 0.010 |
Why?
|
| Male | 2 | 2017 | 42680 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 2415 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 2362 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 5559 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1996 | 53 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 203 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 446 | 0.010 |
Why?
|